Engineering bacteria as interactive cancer therapies

CR Gurbatri, N Arpaia, T Danino - Science, 2022 - science.org
With increasing evidence that microbes colonize tumors, synthetic biology tools are being
leveraged to repurpose bacteria as tumor-specific delivery systems. These engineered …

[HTML][HTML] Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial …

A Bhatwa, W Wang, YI Hassan, N Abraham… - … in Bioengineering and …, 2021 - frontiersin.org
Recombinant proteins are becoming increasingly important for industrial applications, where
Escherichia coli is the most widely used bacterial host for their production. However, the …

Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements

J Kaur, A Kumar, J Kaur - International journal of biological …, 2018 - Elsevier
E. coli is most preferred system used for the production of recombinant proteins in bacteria
and the availability of improved genetic tools/methods are making it more valuable than …

[HTML][HTML] Recombinant protein expression in Escherichia coli: advances and challenges

GL Rosano, EA Ceccarelli - Frontiers in microbiology, 2014 - frontiersin.org
Escherichia coli is one of the organisms of choice for the production of recombinant proteins.
Its use as a cell factory is well-established and it has become the most popular expression …

[HTML][HTML] Recombinant lipases and phospholipases and their use as biocatalysts for industrial applications

GM Borrelli, D Trono - International journal of molecular sciences, 2015 - mdpi.com
Lipases and phospholipases are interfacial enzymes that hydrolyze hydrophobic ester
linkages of triacylglycerols and phospholipids, respectively. In addition to their role as …

Production of biopharmaceuticals in E. coli: current scenario and future perspectives

MN Baeshen, AM Al-Hejin, RS Bora… - … of microbiology and …, 2015 - koreascience.kr
Escherichia coli is the most preferred microorganism to express heterologous proteins for
therapeutic use, as around 30% of the approved therapeutic proteins are currently being …

Enhanced Extracellular Production of IsPETase in Escherichia coli via Engineering of the pelB Signal Peptide

L Shi, H Liu, S Gao, Y Weng, L Zhu - Journal of agricultural and …, 2021 - ACS Publications
Poly (ethylene terephthalate)(PET) is one of the most commonly used plastics worldwide
and its accumulation in the environment is a global problem. PETase from Ideonella …

Production of recombinant proteins by microbes and higher organisms

AL Demain, P Vaishnav - Biotechnology advances, 2009 - Elsevier
Large proteins are usually expressed in a eukaryotic system while smaller ones are
expressed in prokaryotic systems. For proteins that require glycosylation, mammalian cells …

Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements

CJ Huang, H Lin, X Yang - Journal of Industrial Microbiology and …, 2012 - academic.oup.com
Nearly 30% of currently approved recombinant therapeutic proteins are produced in
Escherichia coli. Due to its well-characterized genetics, rapid growth and high-yield …

Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems

K Terpe - Applied microbiology and biotechnology, 2006 - Springer
During the proteomics period, the growth in the use of recombinant proteins has increased
greatly in the recent years. Bacterial systems remain most attractive due to low cost, high …